For Second Time, CMS Covers Cancer Test On Day Of FDA Approval

By John Wilkerson / November 30, 2017 at 5:58 PM

For the second time, CMS agreed to cover a companion diagnostic on the day FDA approved it.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.